Evelien Kuip

689 total citations
35 papers, 353 citations indexed

About

Evelien Kuip is a scholar working on Public Health, Environmental and Occupational Health, Oncology and General Health Professions. According to data from OpenAlex, Evelien Kuip has authored 35 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 16 papers in Oncology and 8 papers in General Health Professions. Recurrent topics in Evelien Kuip's work include Palliative Care and End-of-Life Issues (17 papers), Cancer survivorship and care (9 papers) and Patient-Provider Communication in Healthcare (8 papers). Evelien Kuip is often cited by papers focused on Palliative Care and End-of-Life Issues (17 papers), Cancer survivorship and care (9 papers) and Patient-Provider Communication in Healthcare (8 papers). Evelien Kuip collaborates with scholars based in Netherlands, United States and United Kingdom. Evelien Kuip's co-authors include Ron H.J. Mathijssen, Carin C.D. van der Rijt, Stijn L.W. Koolen, Maarten L. Zandvliet, E.W. Muller, Natasja Raijmakers, Peter de Bruijn, Lonneke V. van de Poll‐Franse, Janneke van Roij and Yvonne Engels and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Evelien Kuip

32 papers receiving 346 citations

Peers

Countries citing papers authored by Evelien Kuip

Since Specialization

Citations

This map shows the geographic impact of Evelien Kuip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelien Kuip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelien Kuip more than expected).

Fields of papers citing papers by Evelien Kuip

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evelien Kuip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelien Kuip. The network helps show where Evelien Kuip may publish in the future.

Co-authorship network of co-authors of Evelien Kuip

This figure shows the co-authorship network connecting the top 25 collaborators of Evelien Kuip. A scholar is included among the top collaborators of Evelien Kuip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evelien Kuip. Evelien Kuip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine Learning–Based Prediction of Clinical Outcomes in Patients With Cancer Receiving Systemic Treatment Using Step Count Data Measured With Smartphones 2025 ·JCO Clinical Cancer Informatics ·(unknown), (unknown), Joeri A J Douma, Leni van Doorn, Evelien Kuip, Henk M.W. Verheul, Laurien M. Buffart	0
2	Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer 2024 ·Journal of Nuclear Medicine ·(unknown), (unknown), Adrienne H. Brouwers, Frederike Bensch, Sjoerd G. Elias, Evelien Kuip, Agnes Jager, Bert van der Vegt, Marjolijn N. Lub–de Hooge, Jasper Emmering, Anne I.J. Arens, Gerben J.C. Zwezerijnen, Daniëlle J. Vugts, C. Willemien Menke‐van der Houven van Oordt, (unknown), Carolina P. Schröder	11
3	Relatives’ Unmet Needs in the Last Year of Life of Patients With Advanced Cancer: Results of a Dutch Prospective, Longitudinal Study (eQuiPe) 2024 ·Journal of Palliative Care ·(unknown), Heidi P. Fransen, Alexander de Graeff, Mathijs P. Hendriks, Wouter K. de Jong, Jeroen S. Kloover, Evelien Kuip, Caroline M.P.W. Mandigers, Dirkje W. Sommeijer, Lonneke van de Poll, Natasja Raijmakers, Lia van Zuylen	1
4	Changes in perception of prognosis in the last year of life of patients with advanced cancer and its associated factors: Longitudinal results of the eQuiPe study 2024 ·Palliative Medicine ·(unknown), Lonneke V. van de Poll‐Franse, (unknown), Hanneke W. M. van Laarhoven, Gerard Vreugdenhil, Inge Henselmans, Linda Brom, Evelien Kuip, Yvette M. van der Linden, Natasja Raijmakers	0
5	Abstract PO2-13-03: Spatial HER2 heterogeneity on HER2-PET in HER2-low and negative disease: potential biomarker for antibody-drug conjugate effect 2024 ·Cancer Research ·Carolien P. Schröder, (unknown), (unknown), Adrienne H. Brouwers, Sjoerd G. Elias, Frederike Bensch, Evelien Kuip, Agnes Jager, Andor W.J.M. Glaudemans, Bert van der Vegt, C. Willemien Menke‐van der Houven van Oordt, Elisabeth G.E. de Vries	2
6	The focus on life-prolonging anticancer treatment hampers shared decision-making in people with advanced cancer: A qualitative embedded multiple-case study 2024 ·Palliative Medicine ·(unknown), M. J. van Geel, Yvonne Engels, (unknown), (unknown), (unknown), Carla M.L. van Herpen, Yvonne Schoon, Henk Schers, (unknown), Evelien Kuip, Marieke Perry	0
7	Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer 2024 ·Diagnostics ·Jorianne Boers, (unknown), Mieke C. Zwager, (unknown), Frederike Bensch, Erik F. J. de Vries, Geke A.P. Hospers, Andor W.J.M. Glaudemans, Adrienne H. Brouwers, (unknown), Sjoerd G. Elias, Evelien Kuip, Carla M.L. van Herpen, Agnes Jager, Astrid A.M. van der Veldt, Daniela E. Oprea‐Lager, (unknown), Bert van der Vegt, C. Willemien Menke‐van der Houven van Oordt, Carolina P. Schröder	3
8	Continuity of care for patients with de novo metastatic cancer during the COVID‐19 pandemic: A population‐based observational study 2024 ·International Journal of Cancer ·(unknown), (unknown), Heidi P. Fransen, (unknown), (unknown), Evelien Kuip, Agnes Jager, Peter W.A. Kunst, Hanneke W. M. van Laarhoven, Jolien Tol, Vivianne C. G. Tjan‐Heijnen, Natasja Raijmakers, Yvette M. van der Linden, Sabine Siesling	1
9	Illness trajectories of incurable solid cancers 2024 ·BMJ ·Eric C. T. Geijteman, Evelien Kuip, (unknown), Diana Lees, Éduardo Bruera	21
10	Monitoring the clinical practice of palliative sedation (PALSED) in patients with advanced cancer: an international, multicentre, non-experimental prospective observational study protocol 2023 ·BMC Palliative Care ·(unknown), Kris Vissers, Carlos Centeno, Johan Menten, Lukas Radbruch, Sebastiano Mercadante, Michaël Van der Elst, Claudio Adile, María Arantzamendi, Evelien Kuip, Sheila Payne, Nancy Preston, Jeroen Hasselaar	5
11	Quality of care and quality of life as experienced by patients with advanced cancer of a rare tumour type: results of the multicentre observational eQuiPe study 2023 ·Journal of Cancer Survivorship ·(unknown), Saskia F. A. Duijts, Hanneke W.M. van Laarhoven, Evelien Kuip, Natasja Raijmakers, Linda Brom	3
12	Reduction in potentially inappropriate end-of-life hospital care for cancer patients during the COVID-19 pandemic: A retrospective population-based study 2023 ·Palliative Medicine ·(unknown), Heidi P. Fransen, Hanneke W. M. van Laarhoven, M.H.J. van den Beuken-van Everdingen, Vivianne C. G. Tjan‐Heijnen, (unknown), Agnes Jager, Lia van Zuylen, Evelien Kuip, Yvette M. van der Linden, Natasja Raijmakers, Sabine Siesling	2
13	Clinical Validity of 16α-[¹⁸F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer 2022 ·Journal of Clinical Oncology ·(unknown), Jorianne Boers, Sjoerd G. Elias, Andor W.J.M. Glaudemans, Erik F. J. de Vries, Geke A.P. Hospers, Michel van Kruchten, Evelien Kuip, Agnes Jager, C. Willemien Menke‐van der Houven van Oordt, Bert van der Vegt, Elisabeth G.E. de Vries, Carolina P. Schröder	38
14	Oncologist responses to advanced cancer patients’ lived illness experiences and effects: an applied conversation analysis study 2022 ·BMC Palliative Care ·(unknown), Wyke Stommel, Carlo Leget, (unknown), Evelien Kuip, Kris Vissers, Yvonne Engels, Anne Wichmann	4
15	Quality of life and quality of care as experienced by patients with advanced cancer and their relatives: A multicentre observational cohort study (eQuiPe) 2022 ·European Journal of Cancer ·Janneke van Roij, Natasja Raijmakers, (unknown), M.H.J. van den Beuken-van Everdingen, Ben van den Borne, Geert-Jan Creemers, (unknown), Evelien Kuip, (unknown), Hanneke W.M. van Laarhoven, Caroline M.P.W. Mandigers, Peter Nieboer, Lilly‐Ann van der Velden, Lia van Zuylen, John Gelissen, (unknown), Linda Brom, Heidi P. Fransen, Lonneke V. van de Poll‐Franse	25
16	Spiritual Well-Being and Associated Factors in Dutch Patients With Advanced Cancer 2021 ·Journal of Pain and Symptom Management ·(unknown), Natasja Raijmakers, Janneke van Roij, Anja Visser, M.H.J. van den Beuken-van Everdingen, Evelien Kuip, Hanneke W.M. van Laarhoven, (unknown), (unknown), Tineke J. Smilde, Carlo Leget, George Fitchett	16
17	Experiences of bereaved family caregivers with shared decision making in palliative cancer treatment: a qualitative interview study 2021 ·BMC Palliative Care ·(unknown), (unknown), (unknown), Carla M.L. van Herpen, Yvonne Schoon, Marieke Perry, (unknown), Evelien Kuip, Yvonne Engels	24
18	Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer 2018 ·PLoS ONE ·Evelien Kuip, Wendy H. Oldenmenger, (unknown), Peter de Bruijn, (unknown), Esther Oomen‐de Hoop, Stijn L.W. Koolen, Carin C.D. van der Rijt, Ron H.J. Mathijssen	4
19	Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients 2016 ·European Journal of Clinical Pharmacology ·(unknown), (unknown), Siv Jönsson, Peter de Bruijn, Evelien Kuip, Amílcar Falcão, Carin C.D. van der Rijt, Ron H.J. Mathijssen	21
20	Fatal pneumonitis after treatment with docetaxel and trastuzumab. 2009 ·Data Archiving and Networked Services (DANS) ·Evelien Kuip, E.W. Muller	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact